JNK/SAPK信号转导通路与多药耐药机制的研究

被引:13
作者
隋华
李琦
机构
[1] 上海中医药大学附属普陀医院肿瘤科
基金
上海市自然科学基金;
关键词
多药耐药; JNK; 信号转导; 肿瘤;
D O I
暂无
中图分类号
R73-3 [肿瘤学实验研究];
学科分类号
100214 ;
摘要
引用
收藏
页码:844 / 847
页数:4
相关论文
共 10 条
[1]   野生型p53基因对肝癌细胞多药耐药的逆转作用及其相关机制 [J].
盖晓东 ;
李国利 ;
黄京子 ;
徐鸿洁 ;
王丹 .
癌症, 2006, (08) :954-959
[2]   Analysis of changes in the proteome of HL-60 promyeloid leukemia cells induced by the proteasome inhibitor PSI [J].
Choi, Mi-Ran ;
Najafi, Farhad ;
Safa, Ahmad R. ;
Drexler, Hannes C. A. .
BIOCHEMICAL PHARMACOLOGY, 2008, 75 (12) :2276-2288
[3]  
Activation of the Apoptotic JNK Pathway Through the Rac1‐Binding Scaffold Protein POSH[J] . Zhiheng Xu,Lloyd A. Greene.Methods in Enzymology . 2006
[4]   Targeting the ERK signaling pathway in cancer therapy [J].
Kohno, M ;
Pouyssegur, J .
ANNALS OF MEDICINE, 2006, 38 (03) :200-211
[5]  
JNK1-dependent antimitotic activity of thiazolidin compounds in human non-small-cell lung and colon cancer cells[J] . F. Teraishi,S. Wu,J. Sasaki,L. Zhang,J. J. Davis,W. Guo,F. Dong,B. Fang.Cellular and Molecular Life Sciences . 2005 (19)
[6]   The JNK signal transduction pathway [J].
Weston, CR ;
Davis, RJ .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2002, 12 (01) :14-21
[7]  
Nuclear factor-kappa B and cancer: its role in prevention and therapy[J] . Alok C Bharti,Bharat B Aggarwal.Biochemical Pharmacology . 2002 (5)
[8]   Signal transduction by the JNK group of MAP kinases [J].
Davis, RJ .
CELL, 2000, 103 (02) :239-252
[9]   Downregulation of JNK/SAPK activity is associated with the cross-resistance to P-glycoprotein-unrelated drugs in multidrug-resistant FM3A/M cells overexpressing P-glycoprotein [J].
Kang, CD ;
Ahn, BK ;
Jeong, CS ;
Kim, KW ;
Lee, HJ ;
Yoo, SD ;
Chung, BS ;
Kim, SH .
EXPERIMENTAL CELL RESEARCH, 2000, 256 (01) :300-307
[10]  
Peptide-bond modified glutathione conjugate analogs modulate GSTpi function in GSH-conjugation, drug sensitivity and JNK signaling. Burg D,Riepsaame J,Pont C, et al. Biochemical Pharmacology . 2006